Nurix Therapeutics NRIX
NASDAQ NRIX
$22.99 -0.35 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Other Accumulated Expenses (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) reported Other Accumulated Expenses of $1.3 million for fiscal Q2 2026 (quarter ended May 31, 2026), up 25.1% from $1.04 million a year earlier but down 32.3% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Other Accumulated Expenses of $2.1 million, down 7.9% from FY2024.

  • Other Accumulated Expenses has a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
  • By fiscal year, Other Accumulated Expenses came in at $2.28 million in FY2024 (+202.9%), $751,000 in FY2023 (-50.0%), $1.5 million in FY2022 (+128.1%) and $659,000 in FY2021 (-5.9%).
  • Five-year quarterly Other Accumulated Expenses spans a low of $551,000 in fiscal Q1 2022 and a high of $2.69 million in fiscal Q1 2025.
  • Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with growth averaging 75.2%.
  • The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q2 2022 (growth of 272.7%); the low point was fiscal Q4 2023 (a decline of 50.0%).
  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $1.93 million (Q1 2026), $2.1 million (Q4 2025) and $1.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Nurix Therapeutics 2.42 Bn 414.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 1.30 Mn
Feb 28, 2026 1.93 Mn
Nov 30, 2025 2.10 Mn
Aug 31, 2025 1.73 Mn
May 31, 2025 1.04 Mn
Feb 28, 2025 2.69 Mn
Nov 30, 2024 2.28 Mn
Aug 31, 2024 662,000.00
May 31, 2024 1.00 Mn
Feb 29, 2024 736,000.00
Nov 30, 2023 751,000.00
Aug 31, 2023 834,000.00
May 31, 2023 1.24 Mn
Feb 28, 2023 1.02 Mn
Nov 30, 2022 1.50 Mn
Aug 31, 2022 1.65 Mn
May 31, 2022 2.24 Mn
Feb 28, 2022 551,000.00
Nov 30, 2021 659,000.00
Aug 31, 2021 628,000.00
API Access

Nurix Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NRIX&period=max&api_key=YOUR_API_KEY